Animal Antimicrobial And Antibiotics Market (2026 - 2033)

Animal Antimicrobial And Antibiotics Market Summary

The global animal antimicrobial and antibiotics market size was valued at USD 752.1 million in 2025 and is projected to grow from USD 778.4 million in 2026 to USD 987.6 million by 2033, at a CAGR of 3.4% from 2026 to 2033. Europe dominated the market, accounting for a revenue share of 30% in 2025. The increasing demand for animal-based food products, the rising prevalence of diseases, and the need to increase livestock productivity are expected to propel global market growth.

In meat production, animals are often kept in confined spaces with many other animals, which can lead to the spread of disease. To prevent and treat these diseases, farmers use antibiotics and other antimicrobials to keep their animals healthy. Therefore, there is a growing demand for these products in the animal agriculture industry. Further, the use of antibiotics and other antimicrobials in animal agriculture has been linked to the development of antibiotic-resistant bacteria, a serious public health concern. This has created a need for new and more effective antibiotics to combat these resistant bacteria. Additionally, with the growing demand for meat as the global population continues to grow, there is a need for more efficient and sustainable meat production practices.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In the U.S., the meat industry still uses medically significant antibiotics on chickens, fish, pigs, and cattle that are raised in crowded and unclean conditions in order to promote their growth and reduce the occurrence and transmission of diseases. The majority of scientific experts agree that this practice contributes to the development of antibiotic resistance in bacteria, which poses a risk to human health.

The market is expected to grow in the coming years due to factors such as increasing demand for animal-based food products, the rising prevalence of diseases, and the need to increase the productivity of livestock. There has been a trend toward reducing the use of antibiotics in North America over the past several years. This is due to concerns about antibiotic resistance, which can occur when bacteria are exposed to antibiotics and evolve to become resistant to them. Overuse of antibiotics in animal agriculture can contribute to the development of antibiotic-resistant bacteria, which can be a threat to public health.

Stringent government regulations have a significant impact on market growth. While regulations are necessary to ensure the safety of animals, they can also restrict the market growth in several ways, such as extensive testing and approval processes for new antibiotics and antimicrobials can increase costs for manufacturers, making it difficult to introduce new products to the market and discourage investment in research and development.

Market Dynamics

Analyst Perspective

The animal antimicrobial and antibiotics industry is increasingly being shaped by regulatory oversight and the growing focus on responsible antibiotic use in livestock production. Future growth will depend less on volume expansion and more on balancing animal health needs with antimicrobial stewardship requirements. Companies with strong regulatory expertise, established veterinary relationships, and diversified animal health portfolios are likely to be better positioned to navigate evolving industry standards. In the coming years, the market is expected to evolve toward more targeted, controlled antibiotic use, making technical expertise and customer relationships increasingly important.

Type Insights

The antimicrobial type segment led the market with the largest revenue share of more than 40% in 2025. Antimicrobials used in animals, also known as veterinary antimicrobials, are drugs used to treat and prevent infectious diseases in animals. These drugs can be used for a variety of animals, including livestock, poultry, and pets. In addition, animal antimicrobials work by either killing or inhibiting the growth of bacteria, viruses, fungi, and other microorganisms. They can be administered orally, topically, or by injection, depending on the specific medication and the condition to be treated in animals. Antimicrobials are commonly used in animal farms to prevent and treat infectious diseases, promote animal growth, and improve feed efficiency. However, the overuse and misuse of antimicrobials can lead to the emergence and spread of antimicrobial-resistant bacteria, posing a threat to animal and human health.

The animal antibiotics segment is expected to grow at the fastest CAGR over the forecast period. Animal antibiotics are medications used to prevent or treat bacterial infections in animals, including livestock, pets, and wildlife. They are similar to the antibiotics used to treat bacterial infections in humans. However, these antibiotics are formulated specifically for use in animals. These antibiotics may be administered orally, injected, or applied topically, depending on the specific medication and the type of infection in the animals being treated, thereby driving higher growth rates for this segment over the coming years.

Livestock Insights

The poultry livestock segment led the market with the largest revenue share of over 40% in 2025. Antimicrobials and antibiotics are commonly used in poultry feed to prevent and treat infections in chickens, ducks, and other poultry. They can be added to the feed or water to support the birds' health and well-being and improve their growth rate. Antimicrobials are compounds that can kill or inhibit the growth of microorganisms such as bacteria, viruses, and fungi in poultry. They are commonly used in poultry feed to prevent and treat bacterial infections that can be transmitted through feed, water, or air. These compounds can be added directly to the feed or water, or administered via injection or other methods to poultry. The use of antimicrobials and antibiotics in pig feed has been a common practice in swine farms to promote growth, prevent diseases, and improve feed efficiency. However, there are concerns about the development of antibiotic-resistant bacteria in animals that can be transferred to humans through food or the environment.

The cattle segment is expected to grow at the fastest CAGR over the forecast period. Antimicrobials are added to cattle feed for various purposes, such as improving health and growth, preventing and controlling diseases, and reducing the risk of bacterial contamination in animal products. Animal antibiotics, for instance, the cattle segment is expected to witness significant growth during the forecast period, owing to the increasing adoption of ionophores to improve feed efficiency, weight gain, and disease control in beef and dairy cattle.

Common antimicrobials and antibiotics used in aquaculture feed include quinolones and sulfonamides. They are often added to fish feed at low doses, either continuously or intermittently, to prevent bacterial infections or to treat infected fish. Solid boards, especially in North America and Europe, are projected to drive demand for OSB over the forecast period. In addition, some feed additives can inhibit the growth of Salmonella and other bacteria in cattle's guts, reducing the risk of contamination in meat and dairy products. However, the use of antimicrobials and antibiotics in animal feed has been contentious owing to concerns about the development of antimicrobial resistance in both animals and humans. Therefore, many countries worldwide have implemented regulations and guidelines to limit or prohibit the use of certain antimicrobials and antibiotics in animal feed.

Regional Insights

The animal antimicrobial and antibiotics market in North America is anticipated to grow at the fastest CAGR during the forecast period, due to rising demand for animal-based food products, the increasing prevalence of animal diseases, and the need to increase livestock productivity. There has been a trend toward reducing antibiotic use in animals in North America over the past several years. This is due to concerns about antibiotic resistance, which can occur when bacteria are exposed to antibiotics and evolve to become resistant. Overuse of antibiotics in animal agriculture can contribute to the development of antibiotic-resistant bacteria, posing a threat to public health.

According to the Food and Agriculture Organization (FAO), poultry meat remains the fastest-growing meat segment globally, driven by rising consumption and demand for affordable animal protein. The U.S. remains the world's largest poultry meat producer, accounting for approximately 17% of global poultry meat output.

Europe Animal Antimicrobial And Antibiotics Market Trends

Europe dominated the global animal antimicrobial and antibiotics market with the largest revenue share of more than 30% in 2025. Europe is home to some of the world's most advanced animal husbandry practices, which include advanced breeding techniques, sophisticated housing systems, and advanced feeding practices. These practices lead to healthier animals that are less susceptible to disease, reducing the need for antibiotics and other antimicrobials.

To learn more about this report, Download Free Sample Report

Key Animal Antimicrobial And Antibiotics Company Insights

The global animal antimicrobial and antibiotics industry is fragmented, with numerous players at both the global and regional levels. These global players face intense competition from each other, regional players with strong distribution networks and strong knowledge of suppliers & regulations, and through mergers and acquisitions.

Key Animal Antimicrobial And Antibiotics Companies

The following key companies have been profiled for this study on the animal antimicrobial and antibiotics market.

• Ashish Life Science

• Ayurvet

• C.H. Boehringer Sohn AG & Co. KG.

• Ceva

• Elanco

• Endovac Animal Health.

• HIPRA, S.A.

• HUVEPHARMA

• Kyoritsuseiyaku Corporation

• Neogen Corporation

• Phibro Animal Health Corporation

• UCBVET Animal Health and Welfare

• Vetoquinol

• Virbac

• Zoetis

Recent Development

• In February 2025, Elanco Animal Health agreed with Medgene to commercialize a highly pathogenic avian influenza (HPAI) vaccine for use in dairy cattle. The collaboration aims to strengthen livestock disease prevention and support sustainable animal production through advanced animal health solutions.

• In December 2025, Zoetis highlighted its diversified R&D pipeline, including 12 potential blockbuster animal health candidates, underscoring continued investment in vaccines, therapeutics, and livestock health solutions. The development reflects ongoing innovation in the animal antimicrobial and animal health market.

• In February 2025, Zoetis announced that the U.S. Department of Agriculture (USDA) granted a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, and Killed Virus for use in chickens. The development strengthens disease prevention efforts in poultry production and supports the animal health market.

Global Animal Antimicrobial and Antibiotics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal antimicrobial and antibiotics market report based on type, livestock, and region:

To learn more about this report, Download Free Sample Report

• Type Outlook (Revenue, USD Million; Volume, Kilotons, 2021 - 2033)

  • Antimicrobial

  • Antibiotics

• Livestock Outlook (Revenue, USD Million; Volume, Kilotons, 2021 - 2033)

  • Cattle

  • Pork

  • Poultry

  • Aquaculture

  • Other Livestock

• Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2021 - 2033)

  • North America

    • U.S.

    • Mexico

  • Europe

    • Germany

    • Spain

    • Russia

    • Turkey

  • Asia Pacific

    • China

    • India

    • Japan

  • Central & South America

    • Brazil

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

Research Methodology

The animal antimicrobial and antibiotics market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each animal antimicrobial and antibiotics segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations